NN7088-4029 A multinational, prospective, open labelled, non-controlled, non-interventional post-authorisation study of turoctocog alfa pegol (N8-GP) during long-term routine prophylaxis and treatment of bleeding episodes in patients with haemophilia A (pathfinder 9)

First published 21/09/2020

Last updated 08/01/2025

EU PAS number:

EUPAS36536

Study

Ongoing

Documents

Study protocol

Initial protocol

4029-protocol-eu-pas-reg-redacted

English (1.07 MB - PDF)View document

Updated protocol

_ Protocol 4029 protocol eu-pas-reg redacted (1)

First published: 22/02/2024

English (715.55 KB - PDF)View document

Study results

Study report

4029 progress report eu-pas-reg 01 redacted

English (263.77 KB - PDF)View document

4029 progress report eu-pas-reg 02 redacted

English (476.39 KB - PDF)View document

Other information

Study, other information

4029 progress report eu-pas-reg 02 redacted.pdf

English (476.39 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs